{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:30:41Z","timestamp":1707525041613},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,16]]},"DOI":"10.7759\/cureus.36270","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T05:04:52Z","timestamp":1679029492000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Case Report of Periorbital Pseudolymphoma"],"prefix":"10.7759","author":[{"given":"Uroosa","family":"Subhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najia","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tariq M","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Arbab","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Unaiza","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-011-9857-4","article-title":"Pseudolymphoma of the orbit","volume":"29","author":"Terada T","year":"2012","unstructured":"Terada T. Pseudolymphoma of the orbit. Med Oncol. 2012, 29:1082-3. 10.1007\/s12032-011-9857-4","journal-title":"Med Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2016.04.004","article-title":"Lymphoid hyperplasia of the orbit and ocular adnexa: a clinical \u200bpathologic review","volume":"61","author":"Andrew NH","year":"2016","unstructured":"Andrew NH, Coupland SE, Pirbhai A, Selva D. Lymphoid hyperplasia of the orbit and ocular adnexa: a clinical \u200bpathologic review. Surv Ophthalmol. 2016, 61:778-90. 10.1016\/j.survophthal.2016.04.004","journal-title":"Surv Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13296","article-title":"IgG4-related skin disease","volume":"171","author":"Tokura Y","year":"2014","unstructured":"Tokura Y, Yagi H, Yanaguchi H, et al.. IgG4-related skin disease. Br J Dermatol. 2014, 171:959-67. 10.1111\/bjd.13296","journal-title":"Br J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(79)35438-0","article-title":"Clinicopathologic characteristics of orbital lymphoid hyperplasia","volume":"86","author":"Jakobiec FA","year":"1979","unstructured":"Jakobiec FA, McLean I, Font RL. Clinicopathologic characteristics of orbital lymphoid hyperplasia. Ophthalmology. 1979, 86:948-66. 10.1016\/s0161-6420(79)35438-0","journal-title":"Ophthalmology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.path.2017.01.002","article-title":"Cutaneous pseudolymphoma","volume":"10","author":"Mitteldorf C","year":"2017","unstructured":"Mitteldorf C, Kempf W. Cutaneous pseudolymphoma. Surg Pathol Clin. 2017, 10:455-76. 10.1016\/j.path.2017.01.002","journal-title":"Surg Pathol Clin"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2017.11.003","article-title":"Drug induced pseudolymphoma","volume":"35","author":"Magro CM","year":"2018","unstructured":"Magro CM, Daniels BH, Crowson AN. Drug induced pseudolymphoma. Semin Diagn Pathol. 2018, 35:247-59. 10.1053\/j.semdp.2017.11.003","journal-title":"Semin Diagn Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2012.288","article-title":"Intraorbital corticosteroid injection for orbital reactive lymphoid hyperplasia","volume":"27","author":"Andrew NH","year":"2013","unstructured":"Andrew NH, Kearney D, Selva D. Intraorbital corticosteroid injection for orbital reactive lymphoid hyperplasia. Eye (Lond). 2013, 27:561-3. 10.1038\/eye.2012.288","journal-title":"Eye (Lond)"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1016\/S0025-6196(11)61189-0","article-title":"Treatment of benign orbital pseudolymphomas with the monoclonal anti-CD20 antibody rituximab","volume":"82","author":"Witzig TE","year":"2007","unstructured":"Witzig TE, Inwards DJ, Habermann TM, et al.. Treatment of benign orbital pseudolymphomas with the monoclonal anti-CD20 antibody rituximab. Mayo Clin Proc. 2007, 82:692-9.","journal-title":"Mayo Clin Proc"},{"key":"ref9","article-title":"Cutaneous pseudolymphoma: a case report with an immunohistochemical study","volume":"6","author":"Terada T","year":"2013","unstructured":"Terada T. Cutaneous pseudolymphoma: a case report with an immunohistochemical study. Int J Clin Exp Pathol. 2013, 6:966-72.","journal-title":"Int J Clin Exp Pathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/139485-a-rare-case-report-of-periorbital-pseudolymphoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:08Z","timestamp":1707508508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/139485-a-rare-case-report-of-periorbital-pseudolymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.36270","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,16]]}}}